Q-Line Biotech IPO Subscription
The Q-Line Biotech IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
As per the latest subscription update, the Q-Line Biotech IPO has received bids for 42,62,45,600 shares against 41,58,800 shares offered, resulting in an overall subscription of 102.49x. the NII category is subscribed 146.33x, Retail Investors 71.44x, and QIBs 123.94x. Within the NII category, BNII is subscribed 178.82x, while SNII is subscribed 81.35x.
- Retail
- 71.44x
- NII
- 146.33x
- QIB
- 123.94x
- Total
- 102.49x
Current GMP
₹112 (+32.65%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Q-Line Biotech IPO Subscription Details ( Mon, 25 May 26 01:42 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 1,188,000 | 147,237,200 | 123.94x |
| Non-Institutional | 891,600 | 130,466,800 | 146.33x |
| BNII (>₹10L) | 594,400 | 106,289,200 | 178.82x |
| SNII (₹2L–₹10L) | 297,200 | 24,177,600 | 81.35x |
| Retail Investors | 2,079,200 | 148,541,600 | 71.44x |
| Total | 4,158,800 | 426,245,600 | 102.49x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved Apps | Applied Apps | Times (x) |
|---|---|---|---|
| Non-Institutional | 743 | 49,781 | 67.00x |
| BNII (>₹10L) | 495 | 31,162 | 62.91x |
| SNII (₹2L–₹10L) | 248 | 18,619 | 75.18x |
| Retail Investors | 2,599 | 185,677 | 71.44x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Q-Line Biotech IPO Live Subscription Status?
You can check the Q-Line Biotech IPO live subscription status on the IPO Master App or the official websites of the NSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Q-Line Biotech IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Q-Line Biotech IPO was subscribed 71.44 times as of Mon, May 25, 2026 07:12 PM. The public issue closed on Mon, May 25, 2026 for bidding.
How to subscribe Q-Line Biotech IPO?
Investors can apply for the Q-Line Biotech IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Q-Line Biotech IPO subscribed?
The Q-Line Biotech IPO was subscribed 102.49x times at the close of bidding period on Mon, May 25, 2026.
How to check Q-Line Biotech IPO allotment?
The Q-Line Biotech IPO allotment was finalized on Tue, May 26, 2026. You can check the Q-Line Biotech IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Q-Line Biotech IPO Be Listed?
The Q-Line Biotech IPO was listed on Fri, May 29, 2026, on the NSE.
What is the Q-Line Biotech IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Q-Line Biotech IPO was subscribed 123.94 times as of Mon, May 25, 2026 07:12 PM.